About This Role

We are seeking a highly seasoned market access leader to shape U.S. market access strategy for Biogen’s Alzheimer’s portfolio, with a primary focus on Leqembi (IV and sub‑cutaneous). This senior‑level role carries enterprise‑wide visibility, serving as a key advisor to Biogen’s executive leadership, a strategic partner to Investor Relations, and a critical interface with Biogen’s alliance partners.

As a strategic integrator across Biogen’s Market Access & Reimbursement (MA&R) organization, Alzheimer’s commercial teams, and alliance counterparts, the Senior Director will influence asset‑level strategy, communicate performance to the highest levels of the company – including the CEO, executive leadership, and Board of Directors – and shape business‑critical decisions on access, reimbursement, and patient adoption.

What You’ll Do

• Shape the long‑range market access vision for Leqembi IV and SubQ, shaping payer, provider, and site‑of‑care strategies across Medicare (Part B & D), Commercial, and Medicaid channels.
• Establish deep, trust‑based relationships with Eisai’s market access executives, serving as Biogen’s senior-most MA&R voice within the alliance.
• Influence strategic choices – including payer strategy, reimbursement initiatives, KPI definitions, SubQ launch positioning, and cross‑company operational alignment.
• Partner directly with Biogen senior leadership, including preparation and briefing for ELT decision forums, portfolio updates, and business reviews.
• Lead development of market access content for Investor Relations, including Q&A preparation, earnings support, external messaging alignment, and scenario analyses.
• Support Board of Directors preparation, shaping clear and compelling narratives around Alzheimer’s access, payer trends, reimbursement challenges/opportunities, and alliance performance.
• Manage governance touchpoints, ensuring Biogen’s perspectives, priorities, and insights shape alliance decisions at senior‑leadership tables.
• Shape the Alzheimer’s access KPI and performance framework, including definition of metrics, dashboard design, insights generation, and monthly/quarterly business reviews with Biogen and Eisai leadership.
• Translate complex access dynamics into executive‑ready storytelling, ensuring clarity across internal stakeholders.
• Guide overall cross‑functional strategic alignment, translating policy, evidence, reimbursement, and trade dynamics into clear strategy, launch plans, execution priorities, and risk‑mitigation pathways for both IV and SubQ formulations.
• Partner closely with alliance and internal stakeholders to ensure Access & Reimbursement Managers (ARMs) and Field Reimbursement teams receive clear direction and real‑time insights that translate strategy into measurable execution improvement
• Regular Travel Required

Who You Are

You are a highly strategic, analytically rigorous senior leader with demonstrated success building and communicating market access strategies for complex specialty biologics. You inspire confidence with executives and alliance partners, can simplify complexity for Investor Relations and Board audiences, and thrive in high‑visibility, high‑stakes roles. You excel at influencing across organizations and navigating the nuanced dynamics of alliance partnerships.

Required Skills

• 15+ years of U.S. Market Access experience with launch leadership in specialty biologics; Alzheimer’s/neuroscience strongly preferred.
• Bachelor’s degree required; advanced degree (MBA, MPH, MS) preferred.
• Experience serving as a advisor to senior leadership, including contributions to Investor Relations, earnings preparation, or Board‑level communications.
• Demonstrated success leading or influencing in alliances/co‑promotions, ideally in situations with high strategic complexity.
• Deep expertise in Medicare (Part B & D), coding/certification pathways, reimbursement mechanics, site‑of‑care economics, and patient support/HUB models.
• Proven ability to define KPIs, derive insights, and lead high‑stakes business reviews.
• Executive presence and exceptional communication skills, including the ability to elevate technical or detailed market access info into crisp narratives for ELT and Board audiences.
• Track record of leading cross‑functional teams and driving impact across large, complex organizations.

#LI-Hybrid

 

Job Level: Management

Additional Information

The base compensation range for this role is: $238,000.00-$327,000.00